ANAVEX LIFE SCIENCES Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 7 of 7 Posts
Alzheimer's Disease: 5 Stocks On Biotech Radars
Video By: Kevin Cook Thursday, April 22, 2021 7:53 PM EDT
What's been interesting for the past couple of years, and especially the last few months, is to watch the rise of emerging, small-cap Biotech companies trying to take on the big AD and other neurological and CNS diseases.
In this video: AVXL, JAZZ, BIIB, AXSM, SAVA
Watch
Top Picks 2020: Anavex
Article By: MoneyShow.com Saturday, January 11, 2020 9:00 PM EDT
This little known, yet promising, bio-pharmaceutical company is worthy of a closer look.
In this article: AVXL
Read
Healthcare Investing Ideas Big And Small
Article By: Marc Lichtenfeld Monday, January 15, 2018 9:00 PM EDT
With a dire need for growth, many in the industry expect the larger biotech and pharmaceutical companies to open their wallets and acquire smaller companies with novel drugs in development.
In this article: BMY, GSK, JNJ, PFE, AVXL, IMMP, BMRN, FOLD, SGEN, MBOT
Read
5 Biomedical Stocks That Are Expected To Surge
Article By: Zacks Investment Research Tuesday, June 27, 2017 5:01 PM EDT
Every investor struggles with balancing risk and reward when choosing their investments. Biomedical companies are known to offer large capital gains and growth prospects, yet they do not always come to fruition.
In this article: GERN, REGN, KDMN, ENZ, AVXL Also: JNJ
Read
E Anavex Announces Positive Phase 2a Results In Patients With Alzheimer's
Article By: Terry Chrisomalis Monday, November 9, 2015 8:58 PM EDT
Today Anavex announced that it had obtained positive phase 2a results for its trial in treating patients with Alzheimer's.
In this article: AVXL
Read
Anavex Life Sciences - Chart Of The Day
Article By: Jim Van Meerten Monday, October 5, 2015 11:30 PM EDT
Since the Trend Spotter signaled a buy on 10/2 the stock gained 18.75%.
In this article: AVXL
Read
Provectus Biopharmaceuticals Concludes FDA Meeting For PV-10 Phase 3; Successful Completion Of AB Science's Futility Test For Masitinib
Article By: BioMedReports Tuesday, February 10, 2015 5:59 AM EDT
Here is a look at some of the headlines for companies that made news in the healthcare sector on February 9, 2015.
In this article: ACHN, AKBS, AKR.L, AVXL, BIOC, BMRN, BSDM, CLDX, CBMG, CEMI, ENSG, GALE, ICUI, ISLT, IART, JUNO, LJPC, LFVN, MJNA, HTGC, NSPH, OREX, RDHL.TA, RCPT, RGLS, RNN, SBRA, WMGI, VBLT
Read
1 to 7 of 7 Posts